Related Experiment Video
Updated: May 1, 2026

06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
27.2K
Current and future applications of the intra-aortic balloon pump
Chris J Kapelios1, John V Terrovitis, John N Nanas
1The 3rd Department of Cardiology, University of Athens School of Medicine, Athens, Greece.
Current Opinion in Cardiology
|April 2, 2014
Summary
Intra-aortic balloon pump (IABP) use requires re-evaluation as evidence challenges traditional indications. New studies explore IABP for high-risk procedures and as a bridge to advanced therapies, suggesting evolving clinical applications.
Area of Science:
- Cardiovascular Medicine
- Medical Devices
- Clinical Trials
Background:
- The intra-aortic balloon pump (IABP) has been a clinical tool for over 40 years.
- Many current indications for IABP use lack robust evidence-based support.
- This review critically examines existing data and novel applications of intra-aortic counterpulsation.
Purpose of the Study:
- To challenge traditional indications for IABP use.
- To evaluate emerging applications of intra-aortic counterpulsation.
- To synthesize current evidence on IABP efficacy in diverse clinical scenarios.
Main Methods:
- Review of recent clinical studies and meta-analyses.
- Analysis of data challenging established IABP indications.
- Evaluation of evidence for new IABP applications.
Main Results:
- Recent studies do not support IABP use in cardiogenic shock post-myocardial infarction.
- IABP may improve long-term outcomes in high-risk percutaneous coronary interventions when used pre-procedure.
- IABP shows promise as a bridge to transplantation or left-ventricular assist device implantation.
Conclusions:
- Further investigation is needed for IABP in cardiogenic shock.
- Newer, well-designed trials are essential to define optimal IABP indications.
- Revisiting existing data and conducting new trials will clarify appropriate IABP use.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753

